Achieve Life Sciences (ACHV) Net Cash Flow (2010 - 2026)
Achieve Life Sciences (ACHV) posted Net Cash Flow of $7.4 million for Q1 2026, up 166.71% on a QoQ basis from -$11.0 million in Q4 2025, and up 2679.25% year-over-year from $265000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Net Cash Flow (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Net Cash Flow history runs 17 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- Quarterly Net Cash Flow rose 2679.25% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.0 million (down 281.44% YoY) and the FY2025 annual result came in at $8.1 million, up 388.27% from the prior year.
- Net Cash Flow was $7.4 million for Q1 2026 at Achieve Life Sciences, up from -$11.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $50.8 million in Q1 2024 and bottomed at -$19.9 million in Q3 2025.
- A 5-year average of -$555000.0 and a median of -$5.1 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2025 — Net Cash Flow plunged 443.93% — and 2026, when it soared 2679.25%.
- Achieve Life Sciences' Net Cash Flow stood at $6.6 million in 2022, then sank by 166.51% to -$4.4 million in 2023, then jumped by 173.46% to $3.2 million in 2024, then plunged by 443.93% to -$11.0 million in 2025, then jumped by 166.71% to $7.4 million in 2026.
- Business Quant data shows ACHV's Net Cash Flow at $7.4 million in Q1 2026, -$11.0 million in Q4 2025, and -$19.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | 7.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.37 Mn |
| Mar 31, 2026 | 7.37 Mn |
| Dec 31, 2025 | -11.04 Mn |
| Dec 31, 2025 | -11.04 Mn |
| Sep 30, 2025 | -19.90 Mn |
| Sep 30, 2025 | -19.90 Mn |
| Jun 30, 2025 | -2.41 Mn |
| Jun 30, 2025 | -2.41 Mn |
| Mar 31, 2025 | 265,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | -5.07 Mn |
| Jun 30, 2024 | -5.07 Mn |
| Mar 31, 2024 | 50.82 Mn |
| Mar 31, 2024 | 50.82 Mn |
| Dec 31, 2023 | -4.37 Mn |
| Dec 31, 2023 | -4.37 Mn |